PMS2 Rheumatoid Arthritis and Ischemic Heart Disease In Patients From Blumenau - Brazil  by Nobre, M & Gomes, R
A634  VA L U E  I N  H E A LT H  1 8  ( 2 0 1 5 )  A 3 3 5 – A 7 6 6  
PMS4
APPlying Weighted CuMulAtive exPoSure ModelS to PAtternS of 
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Objectives: To develop and validate predictive models for estimating risk of early 
diagnosis of knee osteoarthritis (OA) by weighted cumulative exposure (WCE) 
function scores of prior knee pain consultations. MethOds: Both derivation and 
validation datasets were from an electronic healthcare record (EHR) database 
(Consultations in Primary Care Archive [CiPCA]) in England. WCE functions for 
modelling cumulative effect of time-varying knee pain consultations weighted by 
recency was derived as predictive tool in a population based case-control sample 
and validated in a prospective cohort sample. Two sets of WCE function scores: 
WCE (Half-Normal) score and WCE (Spline) score were evaluated and compared 
on model fitness, discrimination, and calibration both in derivation and validation 
phases. Results: People with the most recent and the most frequent knee pain 
consultations were more likely to have high WCE scores (both sets) and these were 
associated with increased risk of knee OA diagnosis both in derivation and valida-
tion phases. Better model fit, discrimination, and calibration were observed for 
models with WCE (Spline). cOnclusiOns: WCE functions can be used to model 
pre-diagnostic symptoms within routine EHR data and may provide novel low-cost 
predictive tools that may contribute to early diagnosis.
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Objectives: To assess the relative efficacy of bisphosphonates (alendronate, risedro-
nate, ibandronate and zoledronate) for the treatment of Osteoporosis using network 
meta-analysis (NMA). MethOds: A systematic review of the literature was conducted 
using PRISMA guidelines. A network meta-analysis was used to determine the relative 
efficacy of treatments on four fracture outcomes (vertebral, non-vertebral, hip and 
wrist) and percentage change in femoral neck bone mineral density (BMD). Treatment 
effects were modelled using an exchangeable treatment effects model. Heterogeneity 
in treatment effects was explored by considering potential treatment effect modifiers 
using meta-regression. Where appropriate, inconsistency between direct and indirect 
evidence was assessed using node-splitting. Results: 46 randomised controlled tri-
als (RCTs) were identified. Twenty seven RCTs provided fracture data and 35 RCTs 
provided BMD data for analysis. Zoledronate was associated with the greatest treat-
ment effect on vertebral fractures (HR 0.41, 95% CrI 0.28-0.56) and percentage change 
in BMD (3.21, 95% CrI 2.52-3.86) compared to Placebo. The greatest treatment effect on 
non-vertebral and wrist fractures was given by risedronate (HR 0.72, 95% CrI 0.53-0.89 
and HR 0.77, 95% CrI 0.44-1.24, respectively). For hip fractures the greatest treatment 
effect was given by alendronate (HR 0.78, 95% CrI 0.44-1.30). cOnclusiOns: All treat-
ments were associated with beneficial effects on fractures and femoral neck BMD 
relative to placebo. For vertebral fractures and percentage change in BMD the treat-
ment effects were statistically significant for all treatments. Pairwise comparisons 
between treatments indicated that no active treatment was statistically significantly 
more effective than any other active treatment for fracture outcomes. There was some 
heterogeneity in treatment effects between studies suggesting differential treatment 
effects according to study characteristics However, there was no evidence of differ-
ential treatment effects with respect to gender and age.
PMS6
CoMPliAnCe With AlloPurinol AMong hyPertenSive PAtientS With 
gout diAgnoSiS And the relAtionShiP to onSet of end-StAge renAl 
diSeASe
Perreault S1, Nuevo J2, Baumgartner S3, Morlock R3
1Université de Montréal, Montreal, QC, Canada, 2Astrazeneca, Madrid, Spain, 3Ardea Biosciences, 
San Diego, CA, USA
Objectives: Risk of end-stage renal disease (ESRD) in both hypertension and 
gout has been examined in the literature. However, the impact of allopurinol 
adherence on primary prevention of ESRD has not been assessed. The objective is 
to evaluate impact of better allopurinol adherence on ESRD onset. MethOds: A 
cohort of 2752 patients with gout diagnosis was reconstructed using the Québec 
RAMQ and MED-ECHO administrative databases. New users of allopurinol, aged 
45-85 years, with a diagnosis of hypertension and treated with an antihypertensive 
drug between 1997-2007 were eligible. A nested case-control design was used to 
study ESRD occurrence. Every ESRD case was matched for age, sex and duration 
of follow-up for up to 15 controls. Adherence level was assessed as medication 
possession ratio. Conditional logistic regression models were used to estimate rate 
ratios (RR) of ESRD adjusting for covariables. Results: Patients had a mean age 
of 68 years, 82% were men, approximately 50% had ≥ 1 cardiovascular disorder, 
33% had dyslipidemia, 21% had diabetes, 15% had chronic kidney disease, and 
21%, 33%, and 42% were taking thiazides, low-dose aspirin, and NSAIDs, respec-
tively. Clinical characteristics were similar among allopurinol adherent versus 
non-adherent patients. Major risk factor for ESRD onset was chronic kidney dis-
ease at stages 1-3 (RR: 8.00; CI: 3.16 -22.3), and hypertension severity (≥ 3 vs. < 3 
antihypertensive treatments) was a trending risk factor as a crude estimate (RR: 
1.94; CI: 0.68-5.51). Of 341 patients (cases, n= 22; controls, n= 319), high adherence 
(≥ 80%) to allopurinol, versus lower adherence (< 80%), was associated with a lower 
rate of ESRD onset (RR: 0.35; confidence interval [CI]: 0.13-0.91). cOnclusiOns: 
This population-based study suggests that better allopurinol adherence may be 
associated with risk reduction of new-onset ESRD in hypertensive patients. Further 
research is needed, as this study was limited by the small number of cases and 
potential residual confounding factors.
MuSCulAr-SKeletAl diSorderS – Clinical outcomes Studies
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Objectives: Postoperative blood-saving is high-priority after every planned surgery. 
The aim of this study was to analyse the effect of positioning of lower extremities on 
the postoperative bleeding after total knee replacement surgery. MethOds: Sixty 
patients from the orthopaedic department of Zala County Hospital who were operated 
on for insertion of a unilateral total knee prosthesis with cement and got autologous 
blood transfusion (age 35-80 years), were randomly assigned to three intervention 
groups. In Group I (n= 20), patients were in normal laying position, in Group II (n= 20), 
hips were positioned in flexion and knee in extension and in Group III (n= 20), hips and 
knees were positioned in 30o flexion in the first 6 postoperative hours. The surgical 
technique, the surgeon and the anticoagulant treatments were the same. Data col-
lection: medical records, haemoglobin and haematocrit. For the clinical parameters, 
t-tests, ANOVA and Scheffe post hoc tests were used. Statistical significance was estab-
lished at the α -level of 0.05, and IBM SPSS 20.0v was used. Results: During the first 
six postoperative hours positioning not affected significantly on the volume of bleed-
ing and recirculated blood volume (Group I: 615.0±247.3, Group II: 600.0±358.2, Group 
III: 715.0±392.3 ml, ANOVA: p= 0.714; post hoc: p1-2= 0.995, p1-3= 0.805, p 2-3= 0.751), 
either in hours 6-72 (Group I: 775.0±227.6, Group II: 762.0±332.8, Group III: 960.0±400.6 
ml, p= 0.335; p1-2= 0.996, p1-3= 0.462, p2-3= 0.414). Most units of homologous transfu-
sion were needed in Group II (10 units). Position had not effect on the intensity of pain 
and value of the active range of motion of the knee (p= 0.682 vs. p = 0.585) either in 
haemoglobin and haematocrit values (p= 0.362 vs. p= 0.559). cOnclusiOns: These 
results of the present study suggest that the postoperative positioning of the lower 
extremities after knee replacement not affected the postoperative bleeding, the pain 
and the range of motion of the knee joint.
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Objectives: Patients with rheumatoid arthritis (RA) have a higher risk of ischemic 
cardiac events compared with the general population. This would be explained 
not only by the greater presence of traditional risk factors, but also by the sys-
temic inflammatory nature of arthritis. To compare the prevalence of ischemic 
heart disease (IHD) in a target RA population with the international prevalence 
data. MethOds: Cross-sectional study including 183 adult patients with code M05-
M06 (ICD-10) attended in primary or secondary care units from Blumenau city, 
southern Brazil, in 2014. Data collection was performed through structured personal 
interview and, if necessary, later by phone. The presence of IHD was defined as 
acute myocardial infarction, unstable angina, percutaneous coronary intervention or 
coronary artery bypass graft that have occurred after the diagnosis of RA. Results: 
153/183 patients were female (83.6%), mean age of 56.9 years and disease mean 
duration of 12.1 years. The number of cases with first acute myocardial infarction, 
unstable angina or myocardial revascularization after the diagnosis of rheumatoid 
arthritis was 7 (3.8%), two men and five women, two of those fatal, one of each sex. 
When the international prevalence are in Denmark 2.6%, Sweden 3.3%, Netherlands 
3.8%, UK 4.8%, France 4.1%, Canada 3.5%, US 3.7%, China 3.5%, Russia 5.1%, New 
Zealand 5.2%. cOnclusiOns: The result shows that the prevalence of coronary 
ischemia in patients with rheumatoid arthritis from Blumenau is similar to the 
prevalence observed in other countries.
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Objectives: Depression is a chronic debilitating disease with high prevalence that 
considerably affects quality of life. The relationship between depression and osteo-
porosis has been demonstrated, but the evidence is heterogeneous. The aim of the 
present study is to investigate about this relationship in the Italian primary care set-
ting. MethOds: This was a retrospective analysis based on data extracted from Italian 
IMS Health Longitudinal Patient Database. Two cohorts have been defined: patients 
with a diagnosis of Depression (Index Date) during the period January 2004 - December 
2010 and without neither Depression neither Osteoporosis diagnosis during the 5 years 
period preceeding the Index Date; patients with a first contact (Index Date) during the 
period January 2004 - December 2010 that are not in the previous cohort (free from 
Depression) and without neither Osteoporosis neither Depression diagnosis during 
the five years period preceeding the Index Date. Patients in both the two cohorts have 
been followed-up until one of the following event occurred first: Osteoporosis diagnosis 
registration, death, end of registration with the GP, 31 December 2013. Osteoporosis 
incidence rates have been separately calculated in the two cohorts and Osteoporosis 
cumulative incidence curves have been estimated using Kaplan Meier methods and 
compared performing log rank tests. Both univariate and multivariate Cox proportional 
hazard models were performed. Results: Osteoporosis incidence was higher in the 
cohort of depressed patients (2.33 cases per 100 person years vs 1.22 cases per 100 
person years) and results were confirmed by the log rank test (p< 0.001). Increased 
risk of developing osteoporosis for depressed patients was shown both by univariate 
proportional hazard model (HR= 1.75, CI= [1.72,1.78]) and multivariate proportional 
hazard model (HR= 1.15, CI= [1.13, 1.17]). cOnclusiOns: Results from this study sug-
gests that the relationship between Depression and Osteoporosis is confirmed also 
in the primary care setting in Italy.
